Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.

Burger MC, Breuer S, Cieplik HC, Harter PN, Franz K, Bähr O, Steinbach JP.

Int J Mol Sci. 2017 Nov 20;18(11). pii: E2469. doi: 10.3390/ijms18112469.

2.

Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.

Zhang J, Liu H, Tong H, Wang S, Yang Y, Liu G, Zhang W.

Contrast Media Mol Imaging. 2017 Mar 20;2017:7064120. doi: 10.1155/2017/7064120. eCollection 2017. Review.

4.

Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential.

Roy A, Libard S, Weishaupt H, Gustavsson I, Uhrbom L, Hesselager G, Swartling FJ, Pontén F, Alafuzoff I, Tchougounova E.

Front Oncol. 2017 Jun 2;7:115. doi: 10.3389/fonc.2017.00115. eCollection 2017.

5.

Chronic cocaine induces HIF-VEGF pathway activation along with angiogenesis in the brain.

Yin W, Clare K, Zhang Q, Volkow ND, Du C.

PLoS One. 2017 Apr 27;12(4):e0175499. doi: 10.1371/journal.pone.0175499. eCollection 2017.

6.

Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.

Svolos P, Reddick WE, Edwards A, Sykes A, Li Y, Glass JO, Patay Z.

AJNR Am J Neuroradiol. 2017 Jun;38(6):1235-1241. doi: 10.3174/ajnr.A5159. Epub 2017 Apr 20.

7.

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.

Burger MC, Mildenberger IC, Wagner M, Mittelbronn M, Steinbach JP, Bähr O.

Int J Mol Sci. 2017 Mar 29;18(4). pii: E726. doi: 10.3390/ijms18040726.

8.

Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.

Murayi R, Chittiboina P.

Childs Nerv Syst. 2016 Dec;32(12):2293-2302. Epub 2016 Sep 9. Review.

9.

Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles.

Behling K, Maguire WF, Di Gialleonardo V, Heeb LE, Hassan IF, Veach DR, Keshari KR, Gutin PH, Scheinberg DA, McDevitt MR.

J Nucl Med. 2016 Nov;57(11):1771-1777. Epub 2016 Jun 3.

10.

Corticosteroids compromise survival in glioblastoma.

Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D.

Brain. 2016 May;139(Pt 5):1458-71. doi: 10.1093/brain/aww046. Epub 2016 Mar 28.

11.

Bevacizumab for glioblastoma.

Narita Y.

Ther Clin Risk Manag. 2015 Dec 1;11:1759-65. doi: 10.2147/TCRM.S58289. eCollection 2015. Review.

12.

The Temporal Pattern of Changes in Serum Biomarker Levels Reveals Complex and Dynamically Changing Pathologies after Exposure to a Single Low-Intensity Blast in Mice.

Ahmed F, Plantman S, Cernak I, Agoston DV.

Front Neurol. 2015 Jun 12;6:114. doi: 10.3389/fneur.2015.00114. eCollection 2015.

13.

Corticosteroid use in neuro-oncology: an update.

Roth P, Happold C, Weller M.

Neurooncol Pract. 2015 Mar;2(1):6-12. Epub 2014 Oct 9.

14.

Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes.

Poh S, Chelvam V, Low PS.

Nanomedicine (Lond). 2015 May;10(9):1439-49. doi: 10.2217/nnm.14.237.

15.

ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.

Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M; American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee.

AJNR Am J Neuroradiol. 2015 Jun;36(6):E41-51. doi: 10.3174/ajnr.A4341. Epub 2015 Apr 23.

16.

Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.

Jiang XD, Qiao Y.

Transl Lung Cancer Res. 2012 Mar;1(1):84-8. doi: 10.3978/j.issn.2218-6751.2011.12.06.

17.

Intertwined regulation of angiogenesis and immunity by myeloid cells.

Rivera LB, Bergers G.

Trends Immunol. 2015 Apr;36(4):240-9. doi: 10.1016/j.it.2015.02.005. Epub 2015 Mar 11. Review.

18.

Gliomas and the vascular fragility of the blood brain barrier.

Dubois LG, Campanati L, Righy C, D'Andrea-Meira I, Spohr TC, Porto-Carreiro I, Pereira CM, Balça-Silva J, Kahn SA, DosSantos MF, Oliveira Mde A, Ximenes-da-Silva A, Lopes MC, Faveret E, Gasparetto EL, Moura-Neto V.

Front Cell Neurosci. 2014 Dec 12;8:418. doi: 10.3389/fncel.2014.00418. eCollection 2014. Review.

19.

Reversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic model.

Kunjithapatham R, Karthikeyan S, Geschwind JF, Kieserman E, Lin M, Fu DX, Ganapathy-Kanniappan S.

Sci Rep. 2014 Oct 29;4:6816. doi: 10.1038/srep06816.

20.

Drowning stars: reassessing the role of astrocytes in brain edema.

Thrane AS, Rangroo Thrane V, Nedergaard M.

Trends Neurosci. 2014 Nov;37(11):620-8. doi: 10.1016/j.tins.2014.08.010. Epub 2014 Sep 15. Review.

Supplemental Content

Support Center